CHEMED CORP
CHENYSETrading Snapshot
- Day Range
- $506.66 – $521.02
- 52-Week Range
- $365.21 – $557.00
- Volume
- $2.44B
- Avg Volume
- $2.29B
- Shares Outstanding
- 13.1M
- Next Earnings
- Dec 7, 2026
Fundamentals Snapshot
- Annual Revenue
- $2.53B
- Last Q Revenue
- $673M
- P/E Ratio
- 25.8
- P/S Ratio
- 2.6x
- EPS (TTM)
- $20.49
- Dividend Yield
- 0.49%
- Dilution (1yr)
- −6.7%
Why Investors Own CHE
- ✓High-growth profile — revenue up +58.1% YoY with expanding US Equity exposure.
- ✓Healthy economics — 58% gross margin and 25% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
CHEMED CORP
CHE
StockOtter · stockotter.spaceAbout CHEMED CORP
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, doctors, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through two segments: VITAS and Roto-Rooter segments. The company offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company also provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Analyst Ratings
ⓘLatest News & Updates
Corient Private Wealth LP Increases Stock Position in Chemed Corporation $CHE
Corient Private Wealth LP raised its stake in shares of Chemed Corporation (NYSE: CHE) by 43.8% in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission
Head to Head Survey: Mangoceuticals (NASDAQ:MGRX) and Chemed (NYSE:CHE)
Chemed (NYSE: CHE - Get Free Report) and Mangoceuticals (NASDAQ: MGRX - Get Free Report) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of th
Waverly Advisors LLC Makes New $546,000 Investment in Chemed Corporation $CHE
Waverly Advisors LLC acquired a new stake in Chemed Corporation (NYSE: CHE) in the undefined quarter, according to its most recent disclosure with the SEC. The fund acquired 1,173 shares of the company's stock, valued at
Roto-Rooter Buys Largest Franchisee Territory
CINCINNATI, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Roto-Rooter Services Company, a wholly owned subsidiary of Chemed Corporation ("Chemed") (NYSE: CHE) announced it has acquired the largest independent Roto-Rooter franchise,
Chemed Corporation (CHE) Presents at 2026 Jefferies Healthcare Services and Technology Conference Transcript
Chemed Corporation (CHE) Presents at 2026 Jefferies Healthcare Services and Technology Conference Transcript
Amundi Has $25.08 Million Holdings in Chemed Corporation $CHE
Amundi increased its position in Chemed Corporation (NYSE: CHE) by 51.5% in the second quarter, according to its most recent 13F filing with the SEC. The firm owned 53,856 shares of the company's stock after purchasing a